BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 19653996)

  • 1. Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-β receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse model.
    Hu Z; Zhang Z; Guise T; Seth P
    Hum Gene Ther; 2010 Nov; 21(11):1623-9. PubMed ID: 20712434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PD-L1 tropism-expanded oncolytic adenovirus enhanced gene delivery efficiency and anti-tumor effects.
    Mei S; Peng S; Vong EG; Zhan J
    Int Immunopharmacol; 2024 Jun; 137():112393. PubMed ID: 38852522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction Notice to: Selective Targeting of Checkpoint Kinase 1 in Tumor Cells with a Novel Potent Oncolytic Adenovirus.
    Gao Q; Zhou J; Huang X; Chen G; Ye F; Lu Y; Li K; Zhuang L; Huang M; Xu G; Wang S; Ma D
    Mol Ther; 2023 Feb; 31(2):600. PubMed ID: 36580917
    [No Abstract]   [Full Text] [Related]  

  • 4. Delivery and Biosafety of Oncolytic Virotherapy.
    Li L; Liu S; Han D; Tang B; Ma J
    Front Oncol; 2020; 10():475. PubMed ID: 32373515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation.
    Dai F; Zhang F; Sun D; Zhang ZH; Dong SW; Xu JZ
    Braz J Med Biol Res; 2015 Jul; 48(7):629-36. PubMed ID: 26017342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.
    Zhao X; Huang S; Luo H; Wan X; Gui Y; Li J; Wu D
    Int J Clin Exp Med; 2014; 7(5):1204-13. PubMed ID: 24995075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.
    Li Y; Zhang B; Zhang H; Zhu X; Feng D; Zhang D; Zhuo B; Li L; Zheng J
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):933-41. PubMed ID: 23443256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect.
    Liu XR; Cai Y; Cao X; Wei RC; Li HL; Zhou XM; Zhang KJ; Wu S; Qian QJ; Cheng B; Huang K; Liu XY
    J Cell Mol Med; 2012 Jun; 16(6):1298-309. PubMed ID: 21794078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting gene-virotherapy of cancer and its prosperity.
    Liu XY
    Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting gene-virotherapy of cancer.
    Liu XY; Gu JF
    Cell Res; 2006 Jan; 16(1):25-30. PubMed ID: 16467873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-regulated oncolytic adenovirus with improved safety for adenocarcinoma therapy.
    Wei N; Fan JK; Gu JF; He LF; Tang WH; Cao X; Liu XY
    Biochem Biophys Res Commun; 2009 Oct; 388(2):234-9. PubMed ID: 19653996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
    Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.